Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement.

Autor: Lalani AA; Department of Medical Oncology, Juravinski Cancer Centre, McMaster, Hamilton, ON, Canada., Kapoor A; St Joseph's Healthcare Hamilton, McMaster University, Hamilton, ON, Canada., Basappa NS; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada., Bhindi B; Southern Alberta Institute of Urology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Bjarnason GA; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada., Bosse D; Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada., Breau RH; Department of Surgery, University of Ottawa, Ottawa, ON, Canada., Canil CM; Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada., Cardenas LM; Department of Medical Oncology, Juravinski Cancer Centre, McMaster, Hamilton, ON, Canada., Castonguay V; Centre de recherche du Centre Hospitalier Universitaire de Québec - Université Laval (CRCHUQc-UL), Centre de recherche sur le cancer (CRC) de l'Université Laval, Québec, QC, Canada., Chavez-Munoz C; Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada., Chu W; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada., Dudani S; Department of Oncology, William Osler Health System, Brampton, ON, Canada., Graham J; University of Manitoba, Winnipeg, MB, Canada., Heng DYC; Department of Medical Oncology, Tom Baker Cancer Center, Calgary, AB, Canada., Kollmannsberger C; BC Cancer - Vancouver Centre, Vancouver, BC, Canada., Lattouf JB; Department of Surgery, University of Montreal, Montreal, QC, Canada., Morgan S; Department of Radiation Oncology, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada., Reaume MN; Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada., Richard PO; Department of Urology, Centre Hospitalier Universitaire de Sherbrooke and Centre de Recherche du CHUS, Sherbrooke, QC, Canada., Swaminath A; Department of Radiation Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada., Tanguay S; Division of Urology, Department of Surgery, McGill University, Montreal, QC, Canada., Wood LA; Division of Medical Oncology, Dalhousie University, Halifax, NS, Canada., Lavallée LT; Division of Urology and Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.

Publikováno v: Canadian Urological Association journal = Journal de l'Association des urologues du Canada [Can Urol Assoc J] 2023 May; Vol. 17 (5), pp. E154-E163.

Pharmacological Inhibition of Endogenous Hydrogen Sulfide Production Slows Bladder Cancer Progression in an Intravesical Murine Model.

Autor: Relouw, Sydney^1,2 (AUTHOR) gdugbart@uwo.ca, Dugbartey, George J.^2,3,4,5 (AUTHOR), McLeod, Patrick² (AUTHOR), Knier, Natasha N.^6,7 (AUTHOR), Santiesteban, Francisco Martinez⁶ (AUTHOR), Foster, Paula J.^6,7 (AUTHOR), Cadieux-Pitre, Heather-Anne⁸ (AUTHOR), Hague, Nicole M.⁸ (AUTHOR), Caine, Jenna⁸ (AUTHOR), Belletti, Kaitlin⁸ (AUTHOR), Major, Sally^2,8 (AUTHOR), O'Neil, Caroline⁷ (AUTHOR), Gabril, Manal Y.⁹ (AUTHOR) manal.gabril@lhsc.on.ca, Moussa, Madeleine⁹ (AUTHOR), Huynh, Melissa J.^3,10 (AUTHOR), Haeryfar, S.M. Mansour^1,6,10,11,12 (AUTHOR), Sener, Alp^1,2,3,10 (AUTHOR) alp.sener@lhsc.on.ca

Publikováno v: Pharmaceuticals (14248247). Sep2024, Vol. 17 Issue 9, p1212. 14p.

Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancer.

Autor: Raven PA; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada., Lysakowski S; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada., Tan Z; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada., D'Costa NM; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada., Moskalev I; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada., Frees S; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.; Department of Urology, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany., Struss W; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada., Matsui Y; Division of Urology, National Cancer Center Hospital, Tokyo, Japan., Narita S; Department of Urology and Hemodialysis/Apheresis, Akita University School of Medicine, Akita, Japan., Buttyan R; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada., Chavez-Munoz C; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada., So AI; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.

Publikováno v: Journal of cellular physiology [J Cell Physiol] 2019 Nov; Vol. 234 (11), pp. 20634-20647. Date of Electronic Publication: 2019 Apr 22.